Abstract
Purpose
Accumulated evidence has indicated that the gut microbiome affected the pharmacology of anti-diabetic agents, and their metabolic products induced by the agents transformed the structure of gastrointestinal microbiota in return. However, the studies around heredity, ethnicity, or living condition, referring to human microbiome were mostly represented by an occidental pattern partial and rare studies that focused on the effect of several first-line hypoglycemic agents on the gut flora in a single medical center. Therefore, we aimed to explore the interaction between gut microbiome and type 2 diabetes (T2D) or hypoglycemics in Chinese population.
Methods
A total of 130 T2D patients with a specific hypoglycemic treatment and 50 healthy volunteers were enrolled in this study. Gut microbiome compositons were analyzed by 16S ribosomal RNA gene-based sequencing protocol.
Results
Hypoglycemic agents contributed to the alteration of specific species in gut bacteria rather than its total diversity. Metformin increased the abundance of Spirochaete, Turicibacter, and Fusobacterium. Insulin also increased Fusobacterium, and α-glucosidase inhibitors (α-GIs) contributed to the plentitude of Bifidobacterium and Lactobacillus. Both metformin and insulin improved taurine and hypotaurine metabolism, and α-GI promoted several amino acid pathways. Although the community of gut microbiota with metformin and insulin showed similarity, significant differences were available in each diabetic group with hypoglycemia.
Conclusions
Gut microbiota is significantly associated with anti-diabetic agents. The gut microbiome and metabolism have shown respective characteristics in different T2D groups, which were also significantly different from the healthy group. This study provides some new insights for identification and exploration of the pathogenesis of T2D.
Similar content being viewed by others
References
K.E. Wellen, J. Clin. Invest. 115, 1111 (2005)
Lancet. 388, 2566 (2016). http://www.chinadaily.com.cn/china/2016-11/15/content_27382697.htm
L. Wang, P. Gao, M. Zhang, Z. Huang, D. Zhang, Q. Deng, Y. Li, Z. Zhao, X. Qin, D. Jin, M. Zhou, X. Tang, Y. Hu, L. Wang, JAMA 317, 2515 (2017)
Y. Xu, L. Wang, J. He, Y. Bi, M. Li, T. Wang, L. Wang, Y. Jiang, M. Dai, J. Lu, M. Xu, Y. Li, N. Hu, J. Li, S. Mi, C.-S. Chen, G. Li, Y. Mu, J. Zhao, L. Kong, J. Chen, S. Lai, W. Wang, W. Zhao, G. Ning, JAMA 310, 948 (2013)
R.C.W. Ma, X. Lin, W. Jia, Lancet Diabetes Endocrinol. 2, 980 (2014)
J. Qin, Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, D. Shen, Y. Peng, D. Zhang, Z. Jie, W. Wu, Y. Qin, W. Xue, J. Li, L. Han, D. Lu, P. Wu, Y. Dai, X. Sun, Z. Li, A. Tang, S. Zhong, X. Li, W. Chen, R. Xu, M. Wang, Q. Feng, M. Gong, J. Yu, Y. Zhang, M. Zhang, T. Hansen, G. Sanchez, J. Raes, G. Falony, S. Okuda, M. Almeida, E. LeChatelier, P. Renault, N. Pons, J.-M. Batto, Z. Zhang, H. Chen, R. Yang, W. Zheng, S. Li, H. Yang, J. Wang, S.D. Ehrlich, R. Nielsen, O. Pedersen, K. Kristiansen, J. Wang, Nature 490, 55 (2012)
K.E. Bouter, D.H. van Raalte, A.K. Groen, M. Nieuwdorp, Gastroenterology 1, (2017)
Y. Vázquez-Baeza, C. Callewaert, J. Debelius, E. Hyde, C. Marotz, J.T. Morton, A. Swafford, A. Vrbanac, P.C. Dorrestein, R. Knight, Annu. Rev. Pharmacol. Toxicol. 58, 253 (2018)
N.M. Koropatkin, E.C. Martens, Cell Metab. 26, 456 (2017)
T.H. M. P; Consortium. Nature 486, 207 (2012)
H.K. Pedersen, V. Gudmundsdottir, H.B. Nielsen, T. Hyotylainen, T. Nielsen, B.A.H. Jensen, K. Forslund, F. Hildebrand, E. Prifti, G. Falony, E. Le Chatelier, F. Levenez, J. Doré, I. Mattila, D.R. Plichta, P. Pöhö, L.I. Hellgren, M. Arumugam, S. Sunagawa, S. Vieira-Silva, T. Jørgensen, J.B. Holm, K. Trošt, M. Consortium, K. Kristiansen, S. Brix, J. Raes, J. Wang, T. Hansen, P. Bork, S. Brunak, M. Oresic, S.D. Ehrlich, O. Pedersen, Nature 535, 376 (2016)
H. Herrema, R.G. IJzerman, M. Nieuwdorp, Diabetologia 60, 613 (2016)
Y. Gu, X. Wang, J. Li, Y. Zhang, H. Zhong, R. Liu, D. Zhang, Q. Feng, X. Xie, J. Hong, H. Ren, W. Liu, J. Ma, Q. Su, H. Zhang, J. Yang, X. Wang, X. Zhao, W. Gu, Y. Bi, Y. Peng, X. Xu, H. Xia, F. Li, X. Xu, H. Yang, G. Xu, L. Madsen, K. Kristiansen, G. Ning, W. Wang, Nat. Commun. 1, 1785 (2017)
H. Wu, E. Esteve, V. Tremaroli, M.T. Khan, R. Caesar, L. Mannerås-Holm, M. Ståhlman, L.M. Olsson, M. Serino, M. Planas-Fèlix, G. Xifra, J.M. Mercader, D. Torrents, R. Burcelin, W. Ricart, R. Perkins, J.M. Fernàndez-Real, F. Bäckhed, Nat. Med. 1, 850–858 (2017)
Y. Kishida, H. Okubo, H. Ohno, K. Oki, M. Yoneda, J. Gastroenterol. 52, 1180 (2017)
V.K. Gupta, S. Paul, C. Dutta, Front. Microbiol. 8, 229 (2017)
M.M. Rodríguez, D. Pérez, F.J. Chaves, E. Esteve, P. Marin-Garcia, G. Xifra, J. Vendrell, M. Jové, R. Pamplona, W. Ricart, M. Portero-Otin, M.R. Chacón, J.M.F. Real, Nat. Publ. Group 1, 14600 (2015) https://www.nature.com/articles/srep14600
T. Magoc, S.L. Salzberg, Bioinformatics 27, 2957 (2011)
J.G. Caporaso, J. Kuczynski, J. Stombaugh, K. Bittinger, F.D. Bushman, E.K. Costello, N. Fierer, A.G. Peña, J.K. Goodrich, J.I. Gordon, G.A. Huttley, S.T. Kelley, D. Knights, J.E. Koenig, R.E. Ley, C.A. Lozupone, D. McDonald, B.D. Muegge, M. Pirrung, J. Reeder, J.R. Sevinsky, P.J. Turnbaugh, W.A. Walters, J. Widmann, T. Yatsunenko, J. Zaneveld, R. Knight, Nat. Methods 7, 335 (2010)
J.R. Cole, Q. Wang, E. Cardenas, J. Fish, B. Chai, R.J. Farris, A.S. Kulam-Syed-Mohideen, D.M. McGarrell, T. Marsh, G.M. Garrity, J.M. Tiedje, Nucleic Acids Res. 37, D141 (2009)
M.G.I. Langille, J. Zaneveld, J.G. Caporaso, D. McDonald, D. Knights, J.A. Reyes, J.C. Clemente, D.E. Burkepile, R.L. Vega Thurber, R. Knight, R.G. Beiko, C. Huttenhower, Nat. Biotechnol. 31, 814 (2013)
A. Tanca, M. Abbondio, A. Palomba, C. Fraumene, V. Manghina, F. Cucca, E. Fiorillo, S. Uzzau, Microbiome 5, 79 (2017)
T. Greiner, F. Bäckhed, Trends Endocrinol. Metab. 22, 117 (2011)
J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, C.A. Thaiss, A.L. Kau, S.C. Eisenbarth, M.J. Jurczak, J.-P. Camporez, G.I. Shulman, J.I. Gordon, H.M. Hoffman, R.A. Flavell, Nature 482, 179 (2012)
R. Jiang, J.E. Manson, J.B. Meigs, J. Ma, N. Rifai, F.B. Hu, JAMA 291, 711 (2004)
B. Su, H. Liu, J. Li, Y. Sunli, B. Liu, D. Liu, P. Zhang, X. Meng, J. Diabetes 7, 729 (2015)
K. Machiels, M. Joossens, J. Sabino, V. De Preter, I. Arijs, V. Eeckhaut, V. Ballet, K. Claes, F. Van Immerseel, K. Verbeke, M. Ferrante, J. Verhaegen, P. Rutgeerts, S. Vermeire, Gut 63, 1275 (2014)
L.K. Brahe, A. Astrup, L.H. Larsen, Obes. Rev. 14, 950 (2013)
D. Gevers, S. Kugathasan, L.A. Denson, Y. Vázquez-Baeza, W. Van Treuren, B. Ren, E. Schwager, D. Knights, S.J. Song, M. Yassour, X.C. Morgan, A.D. Kostic, C. Luo, A. González, D. McDonald, Y. Haberman, T. Walters, S. Baker, J. Rosh, M. Stephens, M. Heyman, J. Markowitz, R. Baldassano, A. Griffiths, F. Sylvester, D. Mack, S. Kim, W. Crandall, J. Hyams, C. Huttenhower, R. Knight, R.J. Xavier, Cell Host Microbe 15, 382 (2014)
L. Chen, J.E. Wilson, M.J. Koenigsknecht, W.-C. Chou, S.A. Montgomery, A.D. Truax, W.J. Brickey, C.D. Packey, N. Maharshak, G.K. Matsushima, S.E. Plevy, V.B. Young, R.B. Sartor, J.P.-Y. Ting, Nat. Immunol. 18, 541–551 (2017)
T. Shao, L. Shao, H. Li, Z. Xie, Z. He, C. Wen, Front. Microbiol. 8, 596 (2017)
J.B. Buse, R.A. DeFronzo, J. Rosenstock, T. Kim, C. Burns, S. Skare, A. Baron, M. Fineman, Diabetes Care dc150488 (2015)
M.-J. Jung, J. Lee, N.-R. Shin, M.-S. Kim, D.-W. Hyun, J.-H. Yun, P.S. Kim, T.W. Whon, J.-W. Bae, Sci. Rep. 6, 30887 (2016)
A.N. Sarangi, A. Goel, A. Singh, A. Sasi, R. Aggarwal, BMC Gastroenterol. 17, 125 (2017)
T.G. Tan, E. Sefik, N. Geva-Zatorsky, L. Kua, D. Naskar, F. Teng, L. Pasman, A. Ortiz-Lopez, R. Jupp, H.J. Wu, Proc. Natl. Acad. Sci. USA 113, E8141 (2016)
N. Geva-Zatorsky, E. Sefik, L. Kua, L. Pasman, T.G. Tan, A. Ortiz-Lopez, T.B. Yanortsang, L. Yang, R. Jupp, D. Mathis, C. Benoist, D.L. Kasper, Cell 168, 928–943.e11 (2017)
K. Winiarska, K. Szymanski, P. Gorniak, M. Dudziak, J. Bryla, Biochimie 91, 261 (2009)
F. Turroni, C. Milani, S. Duranti, L. Mancabelli, M. Mangifesta, A. Viappiani, G.A. Lugli, C. Ferrario, L. Gioiosa, A. Ferrarini, J. Li, P. Palanza, M. Delledonne, D. van Sinderen, and M. Ventura, ISME J. 10,1656–1668 (2016)
Funding
This project has been supported by the National Natural Science Foundation of China under contract no. 31471202 (to L.Z.) and no. 81670822 (to Y.W.); the Shandong Provincial Key Research and Development Program under contract no. 2016YYSP009 (to L.Z.); Weihai Technique Extension Project under contract no. 2016GNS023 (to L.Z.); Qingdao Key Research Project No. 17-3-3-10-nsh (to C.Z.). L.Z. is also supported by the Taishan Scholars Program of Shandong Province (no. tshw20120206).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Research involving human participants and/or animals: this article does not contain any studies with animals performed by any of the authors.
Informed consent
All the subjects signed informed consent beforehand and belonged to the same geographical area. Data were collected by using a standardized questionnaire, including basic information, medical history, and examination results.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Zhang, F., Wang, M., Yang, J. et al. Response of gut microbiota in type 2 diabetes to hypoglycemic agents. Endocrine 66, 485–493 (2019). https://doi.org/10.1007/s12020-019-02041-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-02041-5